![The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-48590-7/MediaObjects/41598_2019_48590_Fig1_HTML.png)
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports
![Clinical small molecule inhibitors of cell membrane receptors in NF-kB... | Download Scientific Diagram Clinical small molecule inhibitors of cell membrane receptors in NF-kB... | Download Scientific Diagram](https://www.researchgate.net/publication/343130391/figure/tbl1/AS:918027516268544@1595886224352/Clinical-small-molecule-inhibitors-of-cell-membrane-receptors-in-NF-kB-pathway.png)
Clinical small molecule inhibitors of cell membrane receptors in NF-kB... | Download Scientific Diagram
![Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology](https://www.frontiersin.org/files/Articles/598444/fimmu-11-598444-HTML-r1/image_m/fimmu-11-598444-g001.jpg)
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology
![NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00210-020-02035-5/MediaObjects/210_2020_2035_Fig1_HTML.png)
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
![IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof-of-concept study - Osteoarthritis and Cartilage IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof-of-concept study - Osteoarthritis and Cartilage](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2086989868/2074386580/gr1.jpg)
IκB kinase inhibition as a potential treatment of osteoarthritis – results of a clinical proof-of-concept study - Osteoarthritis and Cartilage
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration - The Spine Journal NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration - The Spine Journal](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dff6f851-2a79-4f88-ada2-890df0776b23/gr1_lrg.jpg)
NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration - The Spine Journal
![Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability | Circulation Research Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability | Circulation Research](https://www.ahajournals.org/cms/asset/2a3da551-0a3e-43cc-a229-ffb1294e4fd3/circresaha.120.316743.fig06.jpg)
Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability | Circulation Research
![Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence | The EMBO Journal Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence | The EMBO Journal](https://www.embopress.org/cms/asset/8acb2366-e100-4abf-b182-e94666e1ef5c/embj2019104296-abs-0001-m.jpg)
Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence | The EMBO Journal
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation | PLOS Biology
![The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0b36eba3-9839-405e-98a1-e367f40ae6b2/gr1.jpg)
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology
![Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41420-020-0270-7/MediaObjects/41420_2020_270_Fig1_HTML.png)
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
![Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases | Pharmaceutical Patent Analyst Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases | Pharmaceutical Patent Analyst](https://www.future-science.com/cms/10.4155/ppa.13.31/asset/images/medium/figure2.gif)